1,2-distearoyllecithin has been researched along with perflutren in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kadowaki, N; Kodama, T; Maruyama, K; Namai, E; Oda, Y; Okada, N; Suzuki, R; Tachibana, K; Taira, Y; Utoguchi, N | 1 |
1 other study(ies) available for 1,2-distearoyllecithin and perflutren
Article | Year |
---|---|
A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy.
Topics: Animals; Antigen Presentation; Antigens; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Cytotoxicity Tests, Immunologic; Dendritic Cells; Endocytosis; Fluorocarbons; Immunotherapy, Active; Interleukin-2; Liposomes; Mice; Mice, Inbred C57BL; Neoplasms; Ovalbumin; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Sodium Azide; Survival Analysis; T-Lymphocytes, Cytotoxic; Ultrasonics | 2009 |